These findings suggest that coordinated modulation of AA metabolism, particularly through the CYP2J2/EPHX2 balance, could represent a promising therapeutic strategy for restoring metabolic and redox equilibrium in HF. The gene discussed is EPHX2; the disease is hydrops fetalis.